FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Alembic Pharmaceuticals Celecoxib Capsules Recall

Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmac…

Alembic Pharmaceuticals Limited

Risk level
Class II
Reported by FDA
Jun 18, 2025
Recall ID
D-0459-2025
Check your lot numberHow we source this data

Summary

Alembic Pharmaceuticals recalled Celecoxib Capsules starting May 9, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0459-2025 on Jun 18, 2025. Reason: Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule. Status: Ongoing.

Why it was recalled

Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule

Product description

Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-142-71

Lot numbers, UPCs & expiration codes

Batch 2405014780, Exp. Date: Sep. 30, 2027

Where it was sold

Distributed Nationwide and in PR

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0459-2025
Classification
Class II
Status
Ongoing
Recall initiated
May 9, 2025
FDA report date
Jun 18, 2025
Quantity
2,946 500-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Alembic Pharmaceuticals Limited

Original FDA data

Every field from FDA enforcement report D-0459-2025, exactly as published.

Show all FDA fields
City
Panchmahal
Status
Ongoing
Country
India
Event ID
96840
Address
Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol
Code information
Batch 2405014780, Exp. Date: Sep. 30, 2027
Report date
Jun 18, 2025
Product type
Drugs
Recall number
D-0459-2025
Classification
Class II
Recalling firm
Alembic Pharmaceuticals Limited
Product quantity
2,946 500-count bottles
Reason for recall
Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
Voluntary / mandated
Voluntary: Firm initiated
Product description
Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-142-71
Distribution pattern
Distributed Nationwide and in PR
Recall initiation date
May 9, 2025
Initial firm notification
Letter
Center classification date
Jun 6, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0459-2025, published Jun 18, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls